Determination of Irsogladine Using HPLC-ESI-MS/MS in Human Plasma: Application to Bioequivalence Study
- Authors
- Nguyen Huu Hoang; Nguyen Lan Huong; Hong, Sung-Yong; Park, Je Won
- Issue Date
- 2016
- Publisher
- COLEGIO FARMACEUTICOS PROVINCIA DE BUENOS AIRES
- Keywords
- bioequivalence study; HPLC-ESI-MS/MS; human plasma; irsogladine
- Citation
- LATIN AMERICAN JOURNAL OF PHARMACY, v.35, no.8, pp.1894 - 1898
- Indexed
- SCIE
SCOPUS
- Journal Title
- LATIN AMERICAN JOURNAL OF PHARMACY
- Volume
- 35
- Number
- 8
- Start Page
- 1894
- End Page
- 1898
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/90355
- ISSN
- 0326-2383
- Abstract
- A highly sensitive analytical tool for the fast quantification of irsogladine in human plasma was developed. Cleanup using a solid-phase extraction technique is a simple method for extracting both irsogladine and lamotrigine (internal standard) spiked into human plasma: 89.4 +/- 2.4% for irsogladine and 85.9 +/- 3.4% for lamotrigine. The resolvable separation of both analytes through reversed-phase high-performance liquid chromatography (HPLC) was carried out within 5 min. The HPLC-electrospray ionization (ESI)-tandem mass spectrometry (MS) method, which was operated in a selected reaction monitoring mode specific to the target analytes, was verified for use in the quantification of irsogladine. The inter-and intra-day precision (RSD) were < 4% and their accuracies were between 85.9 to 89.8%. The calibration curve for irsogladine spiked into human plasma was linear over the range from 1 to 100 ng/mL; the limit of quantification was estimated to be 1.8 ng/mL. The established method was successfully applied for a bioequivalence study of irsogladine.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Health Sciences > School of Biosystems and Biomedical Sciences > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.